Cytomegalovirus ileitis and hemophagocytic syndrome associated with use of anti-tumor necrosis factor-α antibody

被引：30
|
作者：
Kohara, MM [1 ]
Blum, RN
机构：
[1] Exempla St Joseph Hosp, Denver, CO USA
[2] Presbyterian St Lukes Hosp, Denver, CO USA
来源：
CLINICAL INFECTIOUS DISEASES | 2006年 / 42卷 / 05期
关键词：
D O I：
10.1086/500262
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：733 / 734
页数：2
相关论文
共 50 条
  • [21] Tuberculosis and Biologic Therapies Anti-Tumor Necrosis Factor-α and Beyond
    Godfrey, Mark S.
    Friedman, Lloyd N.
    CLINICS IN CHEST MEDICINE, 2019, 40 (04) : 721 - +
  • [22] Comparison of specific adsorbents for tumor necrosis factor-α and therapeutic anti-tumor necrosis factor-α antibodies:: An in vitro sepsis model
    Schwanzer-Pfeiffer, D.
    Mitteregger, R.
    Rossmanith, E.
    Falkenhagen, D.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2006, 29 (12): : 1140 - 1147
  • [23] Comparison of specific adsorbents for tumor necrosis factor-α and therapeutic anti-tumor necrosis factor-α antibodies: An in vitro sepsis model
    Schwanzer-Pfeiffer, Dagmar
    Mitteregger, R.
    Rossmanith, E.
    Falkenhagen, D.
    International Journal of Artificial Organs, 2006, 29 (12): : 1140 - 1147
  • [24] Anti-tumor necrosis factor-α treatment attenuates adaptive arteriogenesis
    Grundmann, S
    Hoefer, IE
    Ulusans, S
    Schirmer, SH
    van Royen, N
    Buschmann, I
    CIRCULATION, 2004, 110 (17) : 223 - 223
  • [25] Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis
    Haerter, G
    Manfras, BJ
    de Jong-Hesse, Y
    Wilts, H
    Mertens, T
    Kern, P
    Schmitt, M
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (09) : E88 - E94
  • [26] Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naive and anti-tumor necrosis factor-α drug-resistant psoriasis patients
    Lopez Jimenez, Patricio
    Suarez Perez, Jorge Alonso
    Herrera Acosta, Enrique
    Mendiola Fernandez, Maria Victoria
    Fernandez Crehuet, Pablo
    Guimera Martin-Neda, Francisco
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB118 - AB118
  • [27] Tumor Necrosis Factor and Anti-Tumor Necrosis Factor Therapies
    Keystone, Edward C.
    Ware, Carl F.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 : 27 - 39
  • [28] Targeting Oxidative Injury and Cytokines' Activity in the Treatment with Anti-Tumor Necrosis Factor-α Antibody for Complex Regional Pain Syndrome 1
    Miclescu, Adriana A.
    Nordquist, Lena
    Hysing, Eva-Britt
    Butler, Stephen
    Basu, Samar
    Lind, Anne-Li
    Gordh, Torsten
    PAIN PRACTICE, 2013, 13 (08) : 641 - 648
  • [29] Role of Anti-Tumor Necrosis Factor-α Blockers in Inducing Lupus Erythematosus Tumidus in "Rhupus Syndrome"
    Chogle, Arun R.
    Shah, Chirag V.
    Murthy, Anuradha K.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1218 - 1220
  • [30] Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naiive and anti-tumor necrosis factor-α drug-resistant Japanese psoriasis cases
    Takahashi, Naomi
    Noda, Shinji
    Taniguchi, Takashi
    Adachi, Makoto
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (10) : 1194 - 1198
12345